HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Submit a response Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Lai, C.-C. Articles by Tsao, Y.-P. Search for Related Content PubMed PubMed Citation Articles by Lai, C.-C. Articles by Tsao, Y.-P.

Suppression of Choroidal Neovascularization by Adeno-associated Virus Vector Expressing Angiostatin

¹ From the Department of Ophthalmology, Chang-Gung Memorial Hospital, Taoyuan, Taiwan; the ² Department of Microbiology and Immunology, National Defense Medical Center, Taipei, Taiwan; the ³ Department of Molecular Genetics and Biochemistry, University of Pittsburgh, Pennsylvania; and the ⁴ Department of Medical Research, Veteran’s General Hospital, Taipei, Taiwan.

PURPOSE. To test the efficacy of a recombinant adeno-associated virus (rAAV) vector that expresses mouse angiostatin in suppressing experimental choroidal neovascularization (CNV) in a rat model.

METHODS. An rAAV vector, rAAV-angiostatin, was constructed to deliver the mouse angiostatin gene. rAAV-angiostatin and a control virus, rAAV-lacZ, were delivered in vivo by subretinal injection in Brown Norway rats, and the delivery was confirmed by reverse-transcriptase polymerase chain reaction (RT-PCR). For a CNV suppression experiment, CNV was generated by fundus krypton laser photocoagulation 7 days after the viral vector injection and was evaluated by fluorescein angiography (FA) and histology. Apoptosis in retina was analyzed using the TUNEL assay. Inflammation in the retina was investigated by immunohistochemistry, using antibodies that recognize lymphocytes.

RESULTS. rAAV-angiostatin injection led to sustained expression of the angiostatin gene in chorioretinal tissue for up to150 days. FA analysis revealed significant reduction of the average sizes of CNV lesions in rAAV-angiostatin–injected eyes when compared with rAAV-lacZ–injected eyes at both 14 (P = 0.019) and 150 (P = 0.010) days after injection. Moreover, histologic analysis of CNV lesions also revealed significantly smaller lesions in rAAV-angiostatin–injected eyes (P = 0.004). As for adverse effects, rAAV-angiostatin injection did not cause inflammation or apoptosis of cells in retina and choroid.

CONCLUSIONS. This is the first report that subretinal injection of rAAV-angiostatin can significantly reduce the sizes of CNV lesions. This and the absence of apoptosis and inflammation in chorioretinal tissue indicate the feasibility of a gene therapy approach for treatment of CNV disease.

This article has been cited by other articles:

				T.-C. Tsai, Y.-L. Lee, W.-C. Hsiao, Y.-P. Tsao, and S.-L. Chen NRIP, a Novel Nuclear Receptor Interaction Protein, Enhances the Transcriptional Activity of Nuclear Receptors J. Biol. Chem., May 20, 2005; 280(20): 20000 - 20009. [Abstract] [Full Text] [PDF]

				H. Akiyama, T. Tanaka, H. Itakura, H. Kanai, T. Maeno, H. Doi, M. Yamazaki, K. Takahashi, Y. Kimura, S. Kishi, et al. Inhibition of Ocular Angiogenesis by an Adenovirus Carrying the Human von Hippel-Lindau Tumor-Suppressor Gene In Vivo Invest. Ophthalmol. Vis. Sci., May 1, 2004; 45(5): 1289 - 1296. [Abstract] [Full Text] [PDF]

				W.-Y. Shen, S. Y. Lee, I. Yeo, C.-M. Lai, R. Mathur, D. Tan, I. J. Constable, and P. E. Rakoczy Predilection of the Macular Region to High Incidence of Choroidal Neovascularization After Intense Laser Photocoagulation in the Monkey Arch Ophthalmol, March 1, 2004; 122(3): 353 - 360. [Abstract] [Full Text] [PDF]

				Y. Yanagi, Y. Tamaki, Y. Inoue, R. Obata, K. Muranaka, and N. Homma Subconjunctival Doxifluridine Administration Suppresses Rat Choroidal Neovascularization through Activated Thymidine Phosphorylase Invest. Ophthalmol. Vis. Sci., February 1, 2003; 44(2): 751 - 754. [Abstract] [Full Text] [PDF]

				W.-C. Wu, C.-C. Lai, S.-L. Chen, X. Xiao, T.-L. Chen, R. J.-F. Tsai, S.-W. Kuo, and Y.-P. Tsao Gene Therapy for Detached Retina by Adeno-Associated Virus Vector Expressing Glial Cell Line-Derived Neurotrophic Factor Invest. Ophthalmol. Vis. Sci., November 1, 2002; 43(11): 3480 - 3488. [Abstract] [Full Text] [PDF]

				Y. Yanagi, Y. Tamaki, R. Obata, K. Muranaka, N. Homma, H. Matsuoka, and H. Mano Subconjunctival Administration of Bucillamine Suppresses Choroidal Neovascularization in Rat Invest. Ophthalmol. Vis. Sci., November 1, 2002; 43(11): 3495 - 3499. [Abstract] [Full Text] [PDF]